Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
about
Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinomaMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updatePotential mechanisms of hepatitis B virus induced liver injuryMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesMitochondrial dynamics and viral infections: A close nexusFrom hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanismsActivated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma CellsHepatitis B virus molecular biology and pathogenesisChallenges of cancer control in developing countries: current status and future perspective.Hepatitis B virus infection and intrahepatic cholangiocarcinoma.Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population.Hepatitis C virus and other risk factors in hepatocellular carcinoma.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis.Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.Chronic inflammation and immunologic-based constraints in malignant disease.Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C VirusHepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytesModulation of apoptotic signaling by the hepatitis B virus X protein.HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysisHepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma CellsA novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell linesChronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells.Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaIncreased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C Virus.Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma.Interaction of cyclophilin A with a novel binding protein, SR-25, and characterization of their expression pattern in Chinese hepatocellular carcinoma patientsMiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials.Multiple infections and cancer: implications in epidemiology.Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea.Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.
P2860
Q26745585-C025D488-926A-4BB4-A0E3-F716043D6CBCQ26823512-86D88450-92B0-4C5C-BE81-D3918D17FB96Q26825172-77F2C564-03A5-4C48-ADA0-ADA7268AEAD1Q27014079-F45888FD-B18D-4058-BE15-A2D116B69E85Q27015778-081E8741-C05E-4188-9F82-874C44D2681AQ27024630-6DC0E70C-A3F0-4E21-97DE-6ABBFC371588Q28083493-BAE9D422-046E-42F3-AB71-0F641518AC76Q28383729-5DFDA4E9-8A19-4188-931E-431A4FC7FCA7Q28555059-AD7A15C8-3602-4555-88F5-D03F49E179A1Q28818406-F4B366BB-2B82-4C05-AD8D-5E39C7F6CCB0Q30408066-433C4E93-519D-4087-9C3A-F871EDF0D693Q33626806-249BD108-C2BA-45F3-B72E-7890EEE0E0E3Q33826718-863C82BB-E982-42F7-94A9-C99FE7493457Q34137818-12326502-7115-4DED-8F5F-04C282BCA8ABQ34599896-433D2BBA-9C17-4F67-AC72-97F3273AA6CAQ34763225-0C86612F-ADAC-4147-BAC2-E671C42686E4Q34785204-3FA221ED-C09A-4D15-BE76-0B77EE94E13CQ35067194-CCCA2F9B-5C6A-4D15-A083-90FA1E680A26Q35356022-902713A0-8116-4F83-A2DA-CC5DDD5C789FQ35575974-2AFAEB5A-4356-4578-9994-E2F7FA91FFC5Q35652772-87BF843F-21B0-42C0-AC2D-122FFD7DFB14Q35864702-060891F2-BE94-4375-B83D-798191120FBEQ36080826-983F3AA5-2928-437E-9C87-4070DB759FECQ36267305-88043E39-9ECB-4932-99EA-2F9B144CA82AQ36432730-C158C357-ED16-4678-B006-B15F4205C018Q36954007-964D4901-4008-42C3-BCE3-9043EA844664Q36956039-B0E66F7A-E93A-4BB0-A0BB-0169AF5483D5Q37068909-C42C5D73-DC31-4D89-93FD-AABBF37A1ECEQ37094456-C93E360D-AD2F-4CB0-97BB-B78F126640A3Q37190302-A68390A3-F277-49DC-8315-DAFE54C07AC6Q37297666-5977B638-A602-481A-9205-EF515F0CA4D7Q37297724-E32B1549-B585-47B1-B3BE-AC84D5A898CEQ37522290-8A6C35E5-28C0-4D6D-9966-5120D7AC02F7Q37582151-875E7E3E-ECC6-4B07-912F-64F0FD2A51C6Q37715492-6133211B-48B6-4DE8-A15E-7FB35B4CDA33Q37891167-2F4EC346-14DF-451F-A630-0FCBE5BF2E1BQ38100807-44D5EF16-CA1C-4560-82C0-5977FC1CDC36Q38126931-1D53FC3E-7C78-49F2-A678-7831D7AEE18FQ38158226-5415A08A-A327-403E-AAA3-1E5678483E0CQ38212153-21FEE82B-FF3C-42D1-B6BA-0C78B76EB093
P2860
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@ast
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@en
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@nl
type
label
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@ast
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@en
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@nl
prefLabel
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@ast
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@en
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.
@nl
P2860
P1433
P1476
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges
@en
P2093
Michael J Bouchard
P2860
P304
P356
10.1016/J.CANLET.2010.11.014
P407
P577
2010-12-18T00:00:00Z